Health Catalyst COO reports 3,663-share sell-to-cover at $3.36
Rhea-AI Filing Summary
Daniel LeSueur, Chief Operating Officer of Health Catalyst, Inc. (HCAT), reported a sale of 3,663 shares of the issuer's common stock on 09/02/2025 at a price of $3.3627 per share. The filing states this sale was a mandatory "sell to cover" to satisfy tax-withholding obligations arising from the vesting of restricted stock units and not a discretionary trade. After the transaction, the reporting person beneficially owned 198,367 shares. The Form 4 was signed by Benjamin Landry as attorney-in-fact on 09/04/2025. The report documents an insider compliance action rather than an open-market decision.
Positive
- Compliance with equity plan: The sale was conducted under the issuer's mandated "sell-to-cover" tax withholding procedure.
- Transparent reporting: Transaction date, share count, price, and post-transaction holdings are clearly disclosed in the Form 4.
Negative
- Reduction in direct holdings: The reporting person sold 3,663 shares, decreasing reported direct ownership to 198,367 shares.
Insights
TL;DR: Reported sale is a routine sell-to-cover for RSU tax withholding and indicates adherence to the company's equity plan, not an opportunistic sale.
The Form 4 discloses a non-discretionary sale of 3,663 shares at $3.3627 per share to satisfy tax obligations on vested restricted stock units. Such transactions are standard under many equity plans when companies mandate sell-to-cover to meet withholding requirements. The filing documents compliance and transparency; it does not provide evidence of a change in executive sentiment or a voluntary reduction in exposure beyond tax-related mechanics.
TL;DR: Small, mandated disposition with limited informational content for investors; changes reported precisely in holdings.
The transaction reduced direct beneficial ownership by 3,663 shares, leaving 198,367 shares reported as held. The per-share price of $3.3627 is disclosed, and the sale is explicitly tied to withholding for RSU vesting. As a single, plan-driven transaction, it is unlikely to be material to valuation or indicate a shift in insider conviction absent other disclosures.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 3,663 | $3.3627 | $12K |
Footnotes (1)
- F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
AI-generated analysis. How Rhea-AI works. Not financial advice.
